Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Werdan

Showing results (151-160 of 249) with videos related to

Pageof 25
Sort By:
Plos One|April 29, 2014
Inflammation and prolonged QT time: results from the Cardiovascular Disease, Living and Ageing in Halle (CARLA) studyDaniel Medenwald, Jan A Kors, Harald Loppnow, et al.
Plos One|September 27, 2014
Inflammation and renal function after a four-year follow-up in subjects with unimpaired glomerular filtration rate: results from the observational, population-based CARLA cohortDaniel Medenwald, Matthias Girndt, Harald Loppnow, et al.
Proteomics|December 12, 2007
Myocardial ischemia/reperfusion causes VDAC phosphorylation which is reduced by cardioprotection with a p38 MAP kinase inhibitorHansjörg Schwertz, Justin M Carter, Mulati Abdudureheman, et al.
Critical Care Clinics|February 5, 2008
The alteration of autonomic function in multiple organ dysfunction syndromeHendrik Schmidt, Dirk Hoyer, Joachim Wilhelm, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 19, 2014
Elevated troponin in septic patients in the emergency department: frequency, causes, and prognostic implicationsJoachim Wilhelm, Stefan Hettwer, Markus Schuermann, et al.
Medizinische Klinik (Munich, Germany : 1983)|September 25, 2008
Anticoagulant and/or antiplatelet treatment in patients with atrial fibrillation after percutaneous coronary intervention. A single-center experienceLars Maegdefessel, Axel Schlitt, Julie Faerber, et al.
Thrombosis and Haemostasis|February 23, 2010
The direct thrombin inhibitor argatroban effectively prevents cardiac catheter thrombosis in vitroUwe Raaz, Anja Kaeberich, Lars Maegdefessel, et al.
European Journal of Heart Failure|January 20, 2010
The impact of impaired renal function on mortality in patients with acutely decompensated chronic heart failureAmalia Vaz Pérez, Katrin Otawa, Arabel V Zimmermann, et al.
Plos One|June 17, 2024
Impact of QRS misclassifications on heart-rate-variability parameters (results from the CARLA cohort study)Frank Sauerbier, Johannes Haerting, Daniel Sedding, et al.
International Journal of Cardiology|January 23, 2009
ACE-inhibitor therapy and survival among patients with multiorgan dysfunction syndrome (MODS) of cardiac and non-cardiac originHendrik Schmidt, Dirk Hoyer, Mathias Rauchhaus, et al.
Pageof 25

Showing results (151-160 of 249) with videos related to

Sort By:
Pageof 25
Plos One|April 29, 2014
Inflammation and prolonged QT time: results from the Cardiovascular Disease, Living and Ageing in Halle (CARLA) studyDaniel Medenwald, Jan A Kors, Harald Loppnow, et al.
Plos One|September 27, 2014
Inflammation and renal function after a four-year follow-up in subjects with unimpaired glomerular filtration rate: results from the observational, population-based CARLA cohortDaniel Medenwald, Matthias Girndt, Harald Loppnow, et al.
Proteomics|December 12, 2007
Myocardial ischemia/reperfusion causes VDAC phosphorylation which is reduced by cardioprotection with a p38 MAP kinase inhibitorHansjörg Schwertz, Justin M Carter, Mulati Abdudureheman, et al.
Critical Care Clinics|February 5, 2008
The alteration of autonomic function in multiple organ dysfunction syndromeHendrik Schmidt, Dirk Hoyer, Joachim Wilhelm, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 19, 2014
Elevated troponin in septic patients in the emergency department: frequency, causes, and prognostic implicationsJoachim Wilhelm, Stefan Hettwer, Markus Schuermann, et al.
Medizinische Klinik (Munich, Germany : 1983)|September 25, 2008
Anticoagulant and/or antiplatelet treatment in patients with atrial fibrillation after percutaneous coronary intervention. A single-center experienceLars Maegdefessel, Axel Schlitt, Julie Faerber, et al.
Thrombosis and Haemostasis|February 23, 2010
The direct thrombin inhibitor argatroban effectively prevents cardiac catheter thrombosis in vitroUwe Raaz, Anja Kaeberich, Lars Maegdefessel, et al.
European Journal of Heart Failure|January 20, 2010
The impact of impaired renal function on mortality in patients with acutely decompensated chronic heart failureAmalia Vaz Pérez, Katrin Otawa, Arabel V Zimmermann, et al.
Plos One|June 17, 2024
Impact of QRS misclassifications on heart-rate-variability parameters (results from the CARLA cohort study)Frank Sauerbier, Johannes Haerting, Daniel Sedding, et al.
International Journal of Cardiology|January 23, 2009
ACE-inhibitor therapy and survival among patients with multiorgan dysfunction syndrome (MODS) of cardiac and non-cardiac originHendrik Schmidt, Dirk Hoyer, Mathias Rauchhaus, et al.
Pageof 25